Theolytics Limited
Clinical trials sponsored by Theolytics Limited, explained in plain language.
-
Virus therapy tested for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis early-stage trial is testing a new virus-based therapy called THEO-260 for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The main goals are to find the safest and most effective dose and to see if the treatment shows signs …
Phase: PHASE1, PHASE2 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC
-
New virus therapy tested for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis is an early-stage trial testing a new treatment called THEO-260 for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The main goals are to find a safe dose and check for side effects. Eighteen participants will receive six dos…
Phase: PHASE1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Apr 01, 2026 20:26 UTC